Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia

Immune checkpoint inhibitors sometimes cause neuromuscular adverse events. Although a few cases of myasthenia gravis with hyperCKemia triggered by immune checkpoint inhibitors have been described, conclusive evidence remains limited. We conducted a systematic review of published cases of myasthenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamatsu, Koutaro, Nakane, Shunya, Suzuki, Shigeaki, Kosaka, Takayuki, Fukushima, Satoshi, Kimura, Toshihiro, Miyashita, Azusa, Mukaino, Akihiro, Yamakawa, Shiori, Watanabe, Keisuke, Jinnin, Masatoshi, Komohara, Yoshihiro, Ihn, Hironobu, Ando, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243386/
https://www.ncbi.nlm.nih.gov/pubmed/30480036
http://dx.doi.org/10.1002/acn3.654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243386/
https://www.ncbi.nlm.nih.gov/pubmed/30480036
http://dx.doi.org/10.1002/acn3.654

Ejemplares similares